Chromosome transplantation as a novel approach for correcting complex genomic disorders.
Paulis M
Oncotarget. 6(34):35218-30. doi: 10.18632/oncotarget.6143
Correction of a Recessive Genetic Defect by CRISPR-Cas9-Mediated Endogenous Repair.
Susani L
CRISPR J. 1:230-238. doi: 10.1089/crispr.2018.0004
Chromosome Transplantation: Correction of the Chronic Granulomatous Disease Defect in Mouse Induced Pluripotent Stem Cells.
Castelli A
Stem Cells. 2019 Apr 2;37(7):876-887. doi: 10.1002/stem.3006
Current role of autologous and allogeneic stem cell transplantation for relapsed and refractory hodgkin lymphoma.
Castagna L
Mediterr J Hematol Infect Dis. 2015 Feb 15;7(1):e2015015. doi: 10.4084/MJHID.2015.015
Cell therapy: achievements and perspectives.
Bordignon C
Haematologica. 84(12):1110-49.
Counterflow centrifugal elutriation: present and future.
Almici C
Bone Marrow Transplant. 12(2):105-8.
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients.
Pouillon L
Aliment Pharmacol Ther. 2019 Apr 1;49(9):1181-1187. doi: 10.1111/apt.15223
Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide.
Mariotti J
Eur J Haematol. 2019 Feb 13;102(4):357-367. doi: 10.1111/ejh.13214
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
Spina V
Blood. 2018 Feb 15;131(22):2413-2425. doi: 10.1182/blood-2017-11-812073
Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies.
Marconi M
Cell Death Dis. 2013 Oct 17;4(10):e863. doi: 10.1038/cddis.2013.389